drugset / Trial / NCT00992667

Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics

NCT00992667

RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of the study is to investigate the effect of inhaled apocynin on ROS (reactive oxygen species) and NOS (reactive nitrogen species) synthesis in 10 nonsmoking mild asthmatics. Effects of nebulized apocynin (0.5 mg/ml, 6 ml) are assessed in exhaled breath condensate (EBC) after 30, 60 and 120 minutes.

Timeline

Start
2008-06
Primary completion
2008-08
Completion
2008-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Apocynin Small molecule 3 mg Inhaled

Indications